Click to Share
 
 
  1. Latest News
  2. Submit Press Release
  1. PR Home
  2. Latest News
  3. Feeds
  4. Alerts
  5. Submit Free Press Release
  6. Journalist Account
  7. PRNewswire Distribution

personalized medicine Press Releases

  + XML/RSS  



By Woodland Pharmaceuticals
Woodland is partnering with PreThera Research of Quebec, Canada to create a "Living Legacy" Viable Tumor Bank to study cancer recurrence and drug resistance with funding from the government. Woodland's new labs will be the center of this activity.

By Paradigm
Collaboration will enhance clinical trials by identifying proteomic and other predictors of response to targeted cancer therapies.

By Xhale, Inc
The Board of Directors of Xhale, Inc. today announced the appointment of Nauman (Nick) Toor as a board member of Xhale, Inc. Mr.

By GATC Biotech AG
Constance, Germany – GATC Biotech launches its InView™ 2-weeks Exome service and enhanced, customised epigenetic support for its more than 10,000 clients.

By GATC Biotech
Partners in personalised medicine – jointly individualising cancer therapy

By Arrowhead Publishers
Dr. Daniel Grosu of Illumina will present his perspective on the issues surrounding personalized medicine at the 5th Annual Personalized medicine conference in Boston, MA, October 21-22, 2013, an official satellite event to the American Society of Human..

By Proove Biosciences
Five new doctors and leading pain management clinics in Washington State will begin utilizing Proove Biosciences’ Genetic Testing

By Proove Biosciences
Proove Biosciences’ Vice President of Research and Development, Ben Arthur, Exhibited Proove’s Capacity to Commercialize Genetic Technology in Optimizing Pain Treatments

By Arrowhead Publishers
Matthew Zubiller, Decision Management Executive at Mckesson will discuss Understanding the Value of Advanced Diagnostics: Aligning Labs, Clinicians and Payers to Make Better Decisions at the 5th Annual Personalized Medicine Conference

By Mercury Healthcare International
Concierge Medicine Handbook author, Maria Todd invited to write an article in ThePatient.com, a new German lifestyle magazine about being a concierge medicine patient - how and why she chose her doctor, and what its like to be a patient.

By IGDRASOL
IGDRASOL will present updates on Cynviloq™, its late clinical stage paclitaxel nanoparticle formulation.

By IGDRASOL
Sorrento Therapeutics, Inc. ("STI"; SRNE: OB) today announced that it has signed an exclusive option to acquire IGDRASOL, a private company focused on the development of oncologic agents for the treatment of cancers.

By IGDRASOL
IGDRASOL today announced that the Company’s Chief Scientific Officer, Kouros Motamed, Ph.D., will present at the Breakthroughs in Basic & Translational Cancer Research Conference, February 25th, 2013, Maui, HI.

By IGDRASOL
IGDRASOL today announced that the Company’s Chief Operating Officer, Larn Hwang, Ph.D., will present at the Tumor Invasion and Metastasis conference, January 21st , 2013, San Diego, CA.

By IGDRASOL
IGDRASOL today announced that Dr. Vuong Trieu, CEO of IGDRASOL, will discuss an overview of the company and the clinical development program for IG-001: a chemical polymer-bound nanoparticle paclitaxel entering phase III clinical testing.

By IGDRASOL
Personalization of paclitaxel therapy by combination of next generation nanoparticle paclitaxel and point-of-care therapeutic drug monitoring and biomarker testing.

By Cambridge Healthtech Institute
CHI’s 2nd Annual Point-of-Care Diagnostics Symposium, February 11-12, 2013, San Francisco, CA

By Bio-IT World
Next-Gen Technology | Big Data | Personalized Medicine | Bio-ITWorld.com

By Biomiga Diagnostics
Biomiga Diagnostics announces the development of lateral flow point-of-care Therapeutic Drug Monitoring (TDM) assays for Luteinizing Hormone (LH) and Follicle Stimulating Hormone (FSH). These findings will be presented at the AACR 2012

By Cambridge healthtech Institute
CHI confirms new speakers for its keynote session on cancer clinical trials in the era of personalized medicine lead by Roche Holding AG, UCSF Helen Diller Family Comprehensive Cancer Center, and Samuel Oschin Comprehensive Cancer Institute.

All Press Releases

By Woodland Pharmaceuticals
Woodland is partnering with PreThera Research of Quebec, Canada to create a "Living Legacy" Viable Tumor Bank to study cancer recurrence and drug resistance with funding from the government. Woodland's new labs will be the center of this activity.

By Paradigm
Collaboration will enhance clinical trials by identifying proteomic and other predictors of response to targeted cancer therapies.

By Xhale, Inc
The Board of Directors of Xhale, Inc. today announced the appointment of Nauman (Nick) Toor as a board member of Xhale, Inc. Mr.

By Pharmatech Inc.
Exciting new data acquisition will lead to impressive results for Pharmatech's biomarker database

By GATC Biotech AG
Constance, Germany – GATC Biotech launches its InView™ 2-weeks Exome service and enhanced, customised epigenetic support for its more than 10,000 clients.

By GATC Biotech
Partners in personalised medicine – jointly individualising cancer therapy

By FOIRMYS
When you open a 70-year old patient on the operating table and touch the aorta, the feeling may resemble touching an eggshell or sand paper.

By Arrowhead Publishers
Dr. Daniel Grosu of Illumina will present his perspective on the issues surrounding personalized medicine at the 5th Annual Personalized medicine conference in Boston, MA, October 21-22, 2013, an official satellite event to the American Society of Human..

By Proove Biosciences
Five new doctors and leading pain management clinics in Washington State will begin utilizing Proove Biosciences’ Genetic Testing

By Proove Biosciences
Proove Biosciences’ Vice President of Research and Development, Ben Arthur, Exhibited Proove’s Capacity to Commercialize Genetic Technology in Optimizing Pain Treatments

By Arrowhead Publishers
Matthew Zubiller, Decision Management Executive at Mckesson will discuss Understanding the Value of Advanced Diagnostics: Aligning Labs, Clinicians and Payers to Make Better Decisions at the 5th Annual Personalized Medicine Conference

By Proove Biosciences
During the April 27th, 2013 National Drug Take Back Day, 387 Pounds of Prescription Medication was Collected and Disposed

By Mercury Healthcare International
Concierge Medicine Handbook author, Maria Todd invited to write an article in ThePatient.com, a new German lifestyle magazine about being a concierge medicine patient - how and why she chose her doctor, and what its like to be a patient.

By Applied Spectral Imaging Inc.
Delivering a state-of-the-art integrated computerized analysis instrument and cell enrichment solution

By IGDRASOL
IGDRASOL will present updates on Cynviloq™, its late clinical stage paclitaxel nanoparticle formulation.

By Cypher Genomics
Cypher Genomics: Ahead of the Curve A San Diego Company is Poised to Lead the Genome Interpretation Industry SAN DIEGO, C.A., Mar.

By IGDRASOL
Sorrento Therapeutics, Inc. ("STI"; SRNE: OB) today announced that it has signed an exclusive option to acquire IGDRASOL, a private company focused on the development of oncologic agents for the treatment of cancers.

By IGDRASOL
IGDRASOL today announced that the Company’s Chief Scientific Officer, Kouros Motamed, Ph.D., will present at the Breakthroughs in Basic & Translational Cancer Research Conference, February 25th, 2013, Maui, HI.

By IGDRASOL
IGDRASOL today announced that the Company’s Chief Operating Officer, Larn Hwang, Ph.D., will present at the Tumor Invasion and Metastasis conference, January 21st , 2013, San Diego, CA.

By IGDRASOL
IGDRASOL today announced that Dr. Vuong Trieu, CEO of IGDRASOL, will discuss an overview of the company and the clinical development program for IG-001: a chemical polymer-bound nanoparticle paclitaxel entering phase III clinical testing.

By IGDRASOL
Personalization of paclitaxel therapy by combination of next generation nanoparticle paclitaxel and point-of-care therapeutic drug monitoring and biomarker testing.

By Cambridge Healthtech Institute
CHI’s 2nd Annual Point-of-Care Diagnostics Symposium, February 11-12, 2013, San Francisco, CA

By Bio-IT World
Next-Gen Technology | Big Data | Personalized Medicine | Bio-ITWorld.com

By Mary Ann Liebert, Inc., publishers
Many biotech observers maintain that the future of healthcare will largely be based on the field of personalized medicine, reports Genetic Engineering & Biotechnology News (GEN).

By Arrowhead Publishers & Conferences
Arrowhead Publishers & Conferences has just announced a new panel session to take place at their 4th Annual Personalized medicine Conference (Boston, MA, September 12-13, 2012) entitled: The Angel Investor & Venture Capital Perspective

By Arrowhead Publishers & Conferences
September 12 & 13, hear speakers tackle the issues driving, as well as restraining, the clinical delivery of personalized medicine, including coding and reimbursement, whole genome sequencing, and market access challenges for companion diagnostics.

By Cambridge Healthtech Institute
A Two Day Event Focusing on the Challenges in eHealth and Personalized Medicine.

By Biomiga Diagnostics
Biomiga Diagnostics announces the development of lateral flow point-of-care Therapeutic Drug Monitoring (TDM) assays for Luteinizing Hormone (LH) and Follicle Stimulating Hormone (FSH). These findings will be presented at the AACR 2012

By Cambridge healthtech Institute
CHI confirms new speakers for its keynote session on cancer clinical trials in the era of personalized medicine lead by Roche Holding AG, UCSF Helen Diller Family Comprehensive Cancer Center, and Samuel Oschin Comprehensive Cancer Institute.

By Biomiga Diagnostics
Biomiga Diagnostics, maker of quantitative point-of-care tests for Therapeutic Drug Monitoring and biomarker testing to promote personalized medicine, today announced it is joining Astia, a global network serving women-led high growth start-ups.

By Genomic Expression Inc
Exciting new genomics technology can deliver better treatments for less money - It is estimated that only half of all prescribed medicines work on the individual patient

By Raybiotech, Inc.
RayBiotech, Inc., today announced that it has engaged recognized industry expert, David A. Dodd of RiversEdge BioVentures LLC to work with the Company in the areas of Business Development and Strategic Growth Opportunities.

By GENETWORx
GENETWORx has launched a new website to highlight their drug-response DNA testing that helps patients, healthcare professionals and plan sponsors determine the right dose, of the right medication, for the best patient outcome.

By Mary Ann Liebert, Inc., publishers
The convergence of commercial genomic kits and electronic medical records is helping to drive the healthcare industry’s focus on personalized medicine, reports Genetic Engineering & Biotechnology News (GEN)

By Van Andel Institute
First-of-its-kind clinical trial to provide new hope for children with advanced cancer receives FDA approval

By Cambridge Healthtech Institute
Cambridge Healthtech Institute will be hosting the 2nd Annual Companion Diagnostics as an Integral Part of Personalized Medicine Conference in Washington, DC on August 24-25, 2011. This conference is part of CHI’s Next Generation Dx Summit.

By Yuko Ueki, Global Information Inc.
Global Information Inc. would like to present a new market research report, "Personalized Medicine Market Worldwide (2010-2015): By Segments, Technologies, Opportunities, Challenges & Future Forecast" by Renub Research.

By Arrowhead Publishers
A new report from Diaceutics for the first time analyzes which drug companies are best prepared to capitalize on new discoveries in genetic biomarkers and translate them into personalized medicine.

By Arrowhead Publishers and Conferences
Arrowhead Publishers and Conferences will be hosting the 3rd Annual Personalized Medicine Partnerships Conference in Washington, DC on April 11-12, 2011. This conference will shed light on issues of importance to the future of personalized medicine.

By Bio-IT World
Deadline for submissions is February 4, 2011

By Insight Pharma Reports, a division of CHI
Next-Generation Sequencing Spurs Personalized Mitochondrial Medicine Interview Transcript Now Available for Complimentary Download

By Arrowhead Publishers and Conferences
This conference will shed light on issues of importance to the future of personalized medicine, including the importance of Rx-Dx partnerships, adoption and the commercial realities of personalized medicine in the global healthcare marketplace.

By Michele Westergaard
Leading Professionals From Pharmaceutical and Biotechnology Companies Examine Advancements in Genomic Research

By Arrowhead Publishers and Conferences
The era of Personalized Medicine is set to revolutionize the healthcare industry. As our knowledge of genetics and molecular biology rapidly expands, a personalized approach to medical care is becoming increasingly important.

By Visionshopsters
In his report SNP Genotyping and Analysis Markets he looks at SNP analysis instruments, reagents, and related software and services, providing information critical to having an understanding of the business behind this new technology

By Linwright Design
The National Center for Policy Analysis Sees Concierge Medicine as the Affordable Answer

By National Foundation for Cancer Research, Genelex
30,000 breast cancer survivors taking tamoxifen are being put unnecessarily at risk of a reccurence due to slow adoption of a simple genetic test.

By Genelex Corp.
The published reports of Mr. Jackson's medications illustrate an important issue- any two drugs may be safe in combination but the cumulative effect of many drugs can be difficult to detect and very dangerous.

By Bi-Biomics
World-Class Histology that improves pathology diagnosis through better quality. Improved protein preservation and 100X better image detail make slides easier to read and diagnosis more accurate. Research was never so enjoyable as with UltraLight.

By Jim Roche NJ
We Innovate Healthcare. As a research-focused healthcare company, Roche discovers, develops and provides innovative diagnostic and therapeutic products and services that deliver significant benefits to patients and healthcare professionals – from e



Page:
  • 1

Page updated every 10 minutes


  1. SiteMap
  2. Contact PRLog
  3. Privacy Policy
  4. Terms of Service
  5. Copyright Notice
  6. About
  7. Advertise
Like PRLog?
9K2K1K
Click to Share